Next, we conducted transwell invasion assay and wound healing assay which showed that upregulation of ATG9B significantly enhanced cell invasion and migration ability in CRC cells, whereas silencing ATG9B had the opposite effect (Figs. 2A, B and S2F, G). This evidence concerns the gene ATG9B and colorectal carcinoma.